These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19106754)

  • 1. Fluconazole prophylaxis in the neonatal intensive care unit.
    Healy CM; Baker CJ
    Pediatr Infect Dis J; 2009 Jan; 28(1):49-52. PubMed ID: 19106754
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants.
    Aziz M; Patel AL; Losavio J; Iyengar A; Berven M; Schloemer N; Jakubowicz A; Mathai T; McAuley JB
    Pediatr Infect Dis J; 2010 Apr; 29(4):352-6. PubMed ID: 19934791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis.
    Long SS; Stevenson DK
    J Pediatr; 2005 Aug; 147(2):135-41. PubMed ID: 16126036
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
    Healy CM; Campbell JR; Zaccaria E; Baker CJ
    Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis.
    Aghai ZH; Mudduluru M; Nakhla TA; Amendolia B; Longo D; Kemble N; Kaki S; Sutsko R; Saslow JG; Stahl GE
    J Perinatol; 2006 Sep; 26(9):550-5. PubMed ID: 16940972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.
    Healy CM; Baker CJ; Zaccaria E; Campbell JR
    J Pediatr; 2005 Aug; 147(2):166-71. PubMed ID: 16126043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole prophylaxis decreases the combined outcome of invasive Candida infections or mortality in preterm infants.
    Kaufman D
    Pediatrics; 2008 Nov; 122(5):1158-9; author reply 1159. PubMed ID: 18978001
    [No Abstract]   [Full Text] [Related]  

  • 8. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
    Manzoni P; Leonessa M; Galletto P; Latino MA; Arisio R; Maule M; Agriesti G; Gastaldo L; Gallo E; Mostert M; Farina D
    Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal prophylaxis: identification of preterm neonates at highest risk for invasive fungal infection.
    Vendettuoli V; Vento G; Tirone C; Posteraro B; Romagnoli C
    Pediatrics; 2009 Feb; 123(2):e368-9. PubMed ID: 19171602
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of fluconazole in neonatal intensive care units.
    Manzoni P; Mostert M; Jacqz-Aigrain E; Farina D
    Arch Dis Child; 2009 Dec; 94(12):983-7. PubMed ID: 19723639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.
    Bertini G; Perugi S; Dani C; Filippi L; Pratesi S; Rubaltelli FF
    J Pediatr; 2005 Aug; 147(2):162-5. PubMed ID: 16126042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal prophylaxis for the prevention of neonatal candidiasis?
    O'Grady MJ; Dempsey EM
    Acta Paediatr; 2008 Apr; 97(4):430-3. PubMed ID: 18363952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
    Kaufman D; Boyle R; Hazen KC; Patrie JT; Robinson M; Grossman LB
    J Pediatr; 2005 Aug; 147(2):172-9. PubMed ID: 16126045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age.
    Kaufman DA; Cuff AL; Wamstad JB; Boyle R; Gurka MJ; Grossman LB; Patrick P
    J Pediatr; 2011 May; 158(5):759-765.e1. PubMed ID: 21168853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal prophylaxis to prevent neonatal candidiasis: a survey of perinatal physician practices.
    Burwell LA; Kaufman D; Blakely J; Stoll BJ; Fridkin SK
    Pediatrics; 2006 Oct; 118(4):e1019-26. PubMed ID: 16982807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why prevent invasive Candida infections?
    Kaufman DA
    J Perinatol; 2008 Jun; 28(6):385-8. PubMed ID: 18511930
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants.
    Uko S; Soghier LM; Vega M; Marsh J; Reinersman GT; Herring L; Dave VA; Nafday S; Brion LP
    Pediatrics; 2006 Apr; 117(4):1243-52. PubMed ID: 16585321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted fluconazole prophylaxis for high-risk very low birth weight infants.
    Rolnitsky A; Levy I; Sirota L; Shalit I; Klinger G
    Eur J Pediatr; 2012 Oct; 171(10):1481-7. PubMed ID: 22628137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of invasive fungal infection in very low birthweight infants.
    Brecht M; Clerihew L; McGuire W
    Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F65-9. PubMed ID: 18838467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.